This randomized clinical trial aims to evaluate the effects of mentalization-based group psychotherapy in patients diagnosed with anxiety and/or depression disorders. In total 100 users of mental health communitary services will be recruited for this study. Participants will be randomized in two parallel groups: to receive usual acceptance and commitment therapy group intervention (control group) or to receive brief mentalization-based group psychotherapy (intervention group). Participants in the trial will be assessed at baseline and at 3 months.
Participants are 18 years or older.
Participants have a diagnosis of ICD-10 F32, F33, F34, F41.1, F41.2, F43 or F43.2.
Participants have minimal relational skills to participate in group therapy.
Participants agree to be part of the study by giving signed written consent.
Participants have a diagnosis of ICD-10 F10-19, F20-29, F31, F42, F43.1, F60.
Participants with cognitive deficits assessed during the initial interview or diagnosis of ICD-10 F70-79.
Participants with planning or structured suicidal ideation.
Participants with difficulties in relational skills evaluated during the initial interview.